Minnesota Gov. Mark Dayton last week signed a bill that will prohibit the use of the antibacterial ingredient triclosan in consumer hygiene products beginning Jan. 1, 2017, according to an Associated Press report published Monday.
The Food and Drug Administration's Nonprescription Drugs Advisory Committee on Friday voted 11-4 opposed to switching Merck's allergy remedy Singulair from Rx-to-OTC, according to an Associated Press report.
West Virginia took one step closer to making pseudoephedrine products prescription-only, as the state's Senate Committee on Health voted Tuesday to move ahead with the proposal, according to an Associated Press report.
Legislation that would require pharmacy benefit managers to seek licensure from the Oklahoma State Board of Pharmacy if they were to distribute medicines to Oklahoma residents was introduced on Tuesday, according to an AP report.
Personal care maker Johnson & Johnson is on a course to reformulate nearly all of its adult toiletries and cosmetics in less than four years in an effort to remove potentially cancer-causing and other dangerous chemicals.
New graphic cigarette warning labels released last month by the Food and Drug Administration already appear to be having one desired effect: an increase in "quit smoking" queries to the national 1-800-QUIT-NOW smoking cessation line, the Associated Press reported Saturday.
Kansas on Monday officially made the move from a paper tracking system for pseudoephedrine sales to the electronic tracking capabilities afforded through the National Precursor Log Exchange, according to an Associated Press report published Monday.
CVS Caremark made headlines when it announced late in the day on Dec. 3 that former Walmart executive Hank Mullany had been named president of CVS/pharmacy. However, the wires were soon abuzz with news that Walmart had filed a lawsuit against CVS to block the hiring of Mullany.